Please assess the completion status of the following clinical trial:

Trial Title: Treating Oxidative Stress in Children With Autism

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of Autistic Disorder by DSM-IV 299.0 or CARS score \>30~Exclusion Criteria:~* Primary genetic disease with co-morbid autism~* frequent seizures~* recent surgery~* active infection with fever~* high dose vitamin/mineral supplements~* severe gastrointestinal symptoms

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 7 Years
- Healthy Volunteers: f

Study Arms:
- Methyl B12 (Type: EXPERIMENTAL): Subcutaneous injection of 75 micrograms/Kg
- Folinic Acid (Type: EXPERIMENTAL): 400 micrograms orally twice a day

Based on this trial design, predict the completion outcome and termination type (if applicable).